Oruka Therapeutics, Inc. Income Tax Expense
Oruka Therapeutics, Inc. (ORKA) had Income Tax Expense of $0 as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2024-11-13
- Oruka Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2020-12-31 was $0.00.
- Oruka Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2020-09-30 was $0.00.
- Oruka Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2020-06-30 was -$9.00K.
- Oruka Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2019-12-31 was -$16.00K.
- Oruka Therapeutics, Inc. income tax expense (benefit) for fiscal 2023 was $0.00.
- Oruka Therapeutics, Inc. income tax expense (benefit) for fiscal 2022 was $0.00.
- Oruka Therapeutics, Inc. income tax expense (benefit) for fiscal 2021 was $0.00.
- Oruka Therapeutics, Inc. income tax expense (benefit) for fiscal 2020 was -$9.00K.
| Period end | Income Tax Expense (Benefit) | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 114 month | Income Tax Expense (Benefit) 117 month | Income Tax Expense (Benefit) 120 month | Income Tax Expense (Benefit) 123 month | Income Tax Expense (Benefit) 126 month | Income Tax Expense (Benefit) 129 month | Income Tax Expense (Benefit) 132 month | Income Tax Expense (Benefit) 135 month | Income Tax Expense (Benefit) 138 month | Income Tax Expense (Benefit) 141 month | Income Tax Expense (Benefit) 144 month | Income Tax Expense (Benefit) 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | ||||||||||||||||
| 2023-12-31 | $0.00 10-K · filed 2024-02-01 | ||||||||||||||||
| 2022-12-31 | $0.00 10-K · filed 2024-02-01 | ||||||||||||||||
| 2021-12-31 | $0.00 10-K · filed 2023-02-24 | ||||||||||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $0.00 derived: sum of 2 quarters · filed 2022-03-14 | -$9.00K derived: sum of 3 quarters · filed 2022-03-14 | -$9.00K 10-K · filed 2022-03-14 | |||||||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$9.00K derived: sum of 2 quarters · filed 2021-11-02 | -$9.00K 10-Q · filed 2021-11-02 | ||||||||||||||
| 2020-06-30 | -$9.00K 10-Q · filed 2021-08-04 | -$9.00K 10-Q · filed 2021-08-04 | |||||||||||||||
| 2019-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$58.00K derived: sum of 2 quarters · filed 2021-03-18 | -$85.00K derived: sum of 3 quarters · filed 2021-03-18 | -$167.00K 10-K · filed 2021-03-18 | |||||||||||||
| 2019-09-30 | -$42.00K 10-Q · filed 2020-11-02 | -$69.00K derived: sum of 2 quarters · filed 2020-11-02 | -$151.00K 10-Q · filed 2020-11-02 | -$151.00K derived: sum of 4 quarters · filed 2020-11-02 | |||||||||||||
| 2019-06-30 | -$27.00K 10-Q · filed 2020-08-05 | -$109.00K 10-Q · filed 2020-08-05 | -$109.00K derived: sum of 3 quarters · filed 2020-08-05 | -$140.00K derived: sum of 4 quarters · filed 2020-08-05 | |||||||||||||
| 2019-03-31 | -$82.00K 10-Q · filed 2020-05-06 | -$82.00K derived: sum of 2 quarters · filed 2020-05-06 | -$113.00K derived: sum of 3 quarters · filed 2020-05-06 | ||||||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$31.00K derived: sum of 2 quarters · filed 2020-02-18 | -$31.00K 10-K · filed 2020-02-18 | ||||||||||||||
| 2018-09-30 | -$31.00K 10-Q · filed 2019-11-06 | -$31.00K 10-Q · filed 2019-11-06 | |||||||||||||||
| 2017-12-31 | -$61.00K 10-K · filed 2019-02-27 | ||||||||||||||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | ||||||||||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-21 | ||||||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $0.00 derived: sum of 2 quarters · filed 2016-03-17 | $0.00 10-K · filed 2016-03-17 | ||||||||||||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | |||||||||||||||
| 2014-03-31 | -$2.28M 10-Q · filed 2014-05-13 | ||||||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $0.00 derived: sum of 2 quarters · filed 2015-03-19 | $0.00 10-K · filed 2015-03-19 | -$2.28M 10-K · filed 2014-03-20 | |||||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | -$2.28M 10-Q · filed 2013-11-13 | ||||||||||||||
| 2013-06-30 | -$2.28M 10-Q · filed 2013-08-13 | ||||||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 135 month − 10-K 132 month · filed 2013-05-13 | $0.00 derived: sum of 2 quarters · filed 2013-05-13 | $0.00 derived: sum of 3 quarters · filed 2013-05-13 | $0.00 derived: sum of 4 quarters · filed 2013-05-13 | -$2.28M 10-Q · filed 2013-05-13 | ||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 132 month − 10-Q 129 month · filed 2013-03-21 | $0.00 derived: sum of 2 quarters · filed 2013-03-21 | $0.00 derived: sum of 3 quarters · filed 2013-03-21 | $0.00 derived: sum of 4 quarters · filed 2013-03-21 | -$2.28M 10-K · filed 2013-03-21 | ||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 129 month − 10-Q 126 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $0.00 derived: sum of 3 quarters · filed 2012-11-13 | $0.00 derived: sum of 4 quarters · filed 2012-11-13 | -$2.28M 10-Q · filed 2012-11-13 | ||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 126 month − 10-Q 123 month · filed 2012-08-13 | $0.00 derived: sum of 2 quarters · filed 2012-08-13 | $0.00 derived: sum of 3 quarters · filed 2012-08-13 | $0.00 derived: sum of 4 quarters · filed 2012-08-13 | -$2.28M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 123 month − 10-K 120 month · filed 2012-05-14 | $0.00 derived: sum of 2 quarters · filed 2012-05-14 | $0.00 derived: sum of 3 quarters · filed 2012-05-14 | -$2.28M 10-Q · filed 2012-05-14 | |||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 120 month − 10-Q 117 month · filed 2012-03-27 | $0.00 derived: sum of 2 quarters · filed 2012-03-27 | -$2.28M 10-K · filed 2012-03-27 | ||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 117 month − 10-Q 114 month · filed 2011-11-14 | -$2.28M 10-Q · filed 2011-11-14 | |||||||||||||||
| 2011-06-30 | -$2.28M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |